XSTOBRAIN
Market cap20mUSD
Dec 23, Last price
1.40SEK
1D
1.45%
1Q
-29.65%
Jan 2017
-83.15%
IPO
-52.86%
Name
BrainCool AB (publ)
Chart & Performance
P/E
—
P/S
9.67
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
30.97%
Rev. gr., 5y
78.35%
Revenues
23m
+32.06%
Net income
-61m
L+34.34%
CFO
-61m
L+32.19%
Profile
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill systems that facilitates rapid medical cooling treatment in an emergency setting and ensures the continuum of care; Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system offers an easy-to-use intuitive interface, informative graphics, and an automatic feedback loop allowing clinicians to manage their patient rather than a device. The company was incorporated in 2010 and is based in Lund, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 23,227 32.06% | 17,588 89.85% | 9,264 31.74% | |||||
Cost of revenue | 11,111 | 66,007 | 87,944 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 12,116 | (48,419) | (78,680) | |||||
NOPBT Margin | 52.16% | |||||||
Operating Taxes | 105 | 29 | (2) | |||||
Tax Rate | 0.87% | |||||||
NOPAT | 12,011 | (48,447) | (78,680) | |||||
Net income | (61,276) 34.34% | (45,613) 17.71% | (38,750) 3.88% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 56,900 | 116,279 | 23,229 | |||||
BB yield | -5.67% | -80.29% | -3.26% | |||||
| Debt | ||||||||
Debt current | 9 | 35,000 | ||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | (25,063) | (41,665) | 20,281 | |||||
| Cash flow | ||||||||
Cash from operating activities | (61,160) | (46,269) | (24,247) | |||||
CAPEX | (1,342) | (7,400) | (10,815) | |||||
Cash from investing activities | (6,167) | (7,587) | (10,815) | |||||
Cash from financing activities | 50,931 | 81,279 | 36,389 | |||||
FCF | 5,958 | (49,522) | (80,952) | |||||
| Balance | ||||||||
Cash | 25,063 | 41,206 | 13,577 | |||||
Long term investments | 468 | 1,141 | ||||||
Excess cash | 23,901 | 40,794 | 14,255 | |||||
Stockholders' equity | (319,494) | (265,017) | (217,829) | |||||
Invested Capital | 431,230 | 381,249 | 296,777 | |||||
ROIC | 2.96% | |||||||
ROCE | 10.84% | |||||||
| EV | ||||||||
Common stock shares outstanding | 209,908 | 89,948 | 94,904 | |||||
Price | 4.78 196.89% | 1.61 -78.53% | 7.50 17.55% | |||||
Market cap | 1,003,358 592.85% | 144,816 -79.65% | 711,784 36.05% | |||||
EV | 978,295 | 362,989 | 732,065 | |||||
EBITDA | 12,116 | (45,925) | (75,396) | |||||
EV/EBITDA | 80.75 | |||||||
Interest | 618 | 8,045 | 3,309 | |||||
Interest/NOPBT | 5.10% | |||||||